Susan Hasty, Publisher
Table of Contents . . . August 17th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Week | Other Publications
Antibiotic Resistance - Ban On Use In Denmark Lowers Resistance In Food Animals
Gene Delivery - 'Gene Pill' Patent Extended To Include All Proteins Secreted Into Blood
Drug Development - Adjuvant Drug Helps Eradicates Cancer Cells In Solid Tumors
Drug Development - Potential Breast Cancer Immunotherapeutic Under Study
Pharmacoeconomics - Drug Companies Say Criticism Of Spending On Advertising Is Nothing New
AIDS Therapies - Comparing Lamivudine To Emtricitabine Influenced By Cell Line
AIDS Therapies - Grant Facilitates Development Of Novel HIV Treatment
AIDS Therapies - Nevirapine Combination Matches Protease-Inhibitor-Based Regimen
AIDS Therapies - Non-Peptidic Protease Inhibitor Suppresses HIV In Resistant Patients
AIDS Therapies - T-Cell Receptor Antagonist Ligand Being Developed
Antiangiogenesis - Agent Targets And Shuts Down Blood Flow In Solid Tumors
Cancer Therapies - Enzyme Ribonucleotide Reductase Inhibitor Trial Initiated
Colorectal Cancer - Phase I/II Trials Initiated With Antiangiogenesis Drug
Depression - Large Pooled Analysis Of Investigational Drug Reported
Drug Development - Drug Trial Tackles Complicated Skin And Soft Tissue Infection
Drug Development - Novel Interferon-Inducing Molecule Discovered
Herpes Simplex Virus - Flare-Up Treatment Reduced From Five Days To Three
Hypertension - Phase IIb Trial For Drug That Reverses Age-Related Crosslink Stiffening
Idiopathic Respiratory Distress Syndrome - Phase III Trial Of Humanized Surfactant Initiated
Multiple Myeloma - Thalidomide Monotherapy Survival Rates Are Encouraging
Overactive Bladder - More Treatment Options Being Tested And Discussed
Prostate Cancer - Three-Month Formulation Of Drug Approved By FDA
Secondary Amyloidosis - New Drug Promising For Chronic Sufferers
Sepsis - Phase I/IIa Trial Of Nitric Oxide Blocking Drug Begins
Sleep Disorders - Positive Phase II Results With NBI-34060 In Insomnia Patients
Type 2 Diabetes - Investigational Drug Improves Glycemic Control, Provides Other Benefits
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.